Leica Biosystems Nussloch GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Leica Biosystems Nussloch GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6567
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leica Biosystems Nussloch Gmbh (Leica Biosystems) is a medical device company. The company provides histology and anatomical pathology workflow solutions. It offers histology equipment and consumables; immuo histochemistry, in situ hybridization, and fluorescence in situ hybridization (FISH); digital pathology; clinical microscopy, surgery, and radiology products; and research products. Leica Biosystems’ histology equipment includes tissue processors, microtomes, sliding and vibrating blade microtomes, microtomes accessories, cryostats, embedding center modules and accessories, and sample tracking system. The company also provides field and technical support, and training services. Leica Biosystems is headquartered in Nussloch, Germany.

Leica Biosystems Nussloch GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Leica Biosystems Nussloch GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Leica Biosystems Nussloch GmbH, Medical Equipment, Deal Details 12
Asset Purchase 12
Devicor Medical Products Acquires Hydromark Breast Biopsy Marker Portfolio And Related Assets From Biopsy Sciences 12
Partnerships 13
Leica Biosystems Enters into Licensing Agreement with Arno Therapeutics 13
Leica Biosystems Enters into Distribution Agreement with Kub Technologies 14
Clearbridge BioMedics and Leica Biosystems Enter into Co-Marketing Partnership 15
Clearbridge Enters into Agreement with Leica Biosystems 16
Bayer Enters into Co-Development Agreement with Leica Biosystems 17
Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 18
Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 19
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 20
RareCyte Enters into Co-Marketing Agreement with Leica Biosystems 21
Leica Biosystems Nussloch Partners with NovoPath 22
Leica Biosystems Nussloch Partners with Mayo Clinic 23
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 24
Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 25
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 26
Arno Therapeutics Enters Into Co-Development Agreement With Leica Biosystems 27
Leica Biosystems Enters Into Agreement With Aspera For Data Distribution Solution 28
Leica Biosystems And Synthon Biopharma Enter Into Agreement To Develop Companion Diagnostic Test For Targeted Cancer Therapies 29
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 30
Devicor Medical Products Enters Into Co-Marketing Agreement With Carbon Medical Technologies 31
Acquisition 32
Leica Biosystems Nussloch Acquires Devicor Medical from GTCR 32
Leica Biosystems Acquires Kreatech Diagnostics 33
Leica Microsystems And Leica Biosystems Acquire Aotec Instrumentos 34
Leica Biosystems Nussloch GmbH – Key Competitors 35
Leica Biosystems Nussloch GmbH – Key Employees 36
Leica Biosystems Nussloch GmbH – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Product News 38
May 30, 2018: Rotary Microtome Solutions Provide Pathology Labs High Quality Sectioning and Enhanced User Safety 38
Apr 12, 2018: Leica Biosystems Showcases Aperio Digital Pathology Scanners and Image Analysis Algorithms at American Association of Cancer Research Annual Meeting 39
Feb 01, 2018: Aiming to improve pathology lab management leica biosystems builds on advanced staining legacy with next gen BOND-III IHC and ISH stainer 40
Mar 28, 2017: Advances in Leica Biosystems Aperio VERSA Digital Pathology for Cancer Researchers Showcased at AACR 2017 41
Mar 17, 2017: Leica Biosystems introduces ACD’s RNAscope technology for use on BOND-III 42
Other Significant Developments 43
Mar 02, 2017: Leica Biosystems and Leeds Hospital establish strategic partnership to provide quantifiable benefits of digital pathology 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Leica Biosystems Nussloch GmbH, Medical Equipment, Key Facts 2
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Leica Biosystems Nussloch GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Leica Biosystems Nussloch GmbH, Deals By Market, 2012 to YTD 2018 9
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Devicor Medical Products Acquires Hydromark Breast Biopsy Marker Portfolio And Related Assets From Biopsy Sciences 12
Leica Biosystems Enters into Licensing Agreement with Arno Therapeutics 13
Leica Biosystems Enters into Distribution Agreement with Kub Technologies 14
Clearbridge BioMedics and Leica Biosystems Enter into Co-Marketing Partnership 15
Clearbridge Enters into Agreement with Leica Biosystems 16
Bayer Enters into Co-Development Agreement with Leica Biosystems 17
Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 18
Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 19
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 20
RareCyte Enters into Co-Marketing Agreement with Leica Biosystems 21
Leica Biosystems Nussloch Partners with NovoPath 22
Leica Biosystems Nussloch Partners with Mayo Clinic 23
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 24
Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 25
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 26
Arno Therapeutics Enters Into Co-Development Agreement With Leica Biosystems 27
Leica Biosystems Enters Into Agreement With Aspera For Data Distribution Solution 28
Leica Biosystems And Synthon Biopharma Enter Into Agreement To Develop Companion Diagnostic Test For Targeted Cancer Therapies 29
Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 30
Devicor Medical Products Enters Into Co-Marketing Agreement With Carbon Medical Technologies 31
Leica Biosystems Nussloch Acquires Devicor Medical from GTCR 32
Leica Biosystems Acquires Kreatech Diagnostics 33
Leica Microsystems And Leica Biosystems Acquire Aotec Instrumentos 34
Leica Biosystems Nussloch GmbH, Key Competitors 35
Leica Biosystems Nussloch GmbH, Key Employees 36
Leica Biosystems Nussloch GmbH, Subsidiaries 37

List of Figures
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Leica Biosystems Nussloch GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Leica Biosystems Nussloch GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sun Pharmaceutical Industries Ltd:企業のM&A・事業提携・投資動向
    Sun Pharmaceutical Industries Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sun Pharmaceutical Industries Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Panoramic Universal Limited
    Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report Summary Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Manulife Holdings Berhad:企業の戦略・SWOT・財務情報
    Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cenovus Energy Inc (CVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Cenovus Energy Inc (Cenovus Energy) is an integrated energy company, which explores, develops, produces and markets crude oil, natural gas liquids (NGLs) and natural gas. Cenovus Energy produces natural gas and oil through conventional and oil sands reserves in Athabasca region of northeaste …
  • Infinera Corporation:戦略・SWOT・企業財務分析
    Infinera Corporation - Strategy, SWOT and Corporate Finance Report Summary Infinera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Zimmer Biomet Holdings Inc.:企業のM&A・事業提携・投資動向
    Zimmer Biomet Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zimmer Biomet Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Insurance Corporation Of British Columbia:企業の戦略・SWOT・財務情報
    Insurance Corporation Of British Columbia - Strategy, SWOT and Corporate Finance Report Summary Insurance Corporation Of British Columbia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Sunrise Senior Living LLC:企業の戦略・SWOT・財務情報
    Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Senior Living LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Turkiye Garanti Bankasi AS:戦略・SWOT・企業財務分析
    Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Luxottica Group S.p.A.:企業の戦略・SWOT・財務情報
    Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Adana Cimento Sanayii Tas:企業の戦略・SWOT・財務分析
    Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report Summary Adana Cimento Sanayii Tas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Seikagaku Corp (4548):企業の財務・戦略的SWOT分析
    Summary Seikagaku Corp (Seikagaku) is a manufacturer and supplier of pharmaceuticals and medical devices. The company offers products such as pharmaceuticals and medical devices, bulk products, endotoxin-detecting reagents and oral care products. It also manufactures and markets pharmaceutical produ …
  • MDU Resources Group Inc (MDU):企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Banque Nationale Agricole SA:企業の戦略・SWOT・財務分析
    Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report Summary Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • University of New Mexico-製薬・医療分野:企業M&A・提携分析
    Summary University of New Mexico (UNM) is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as continuing education, evening and weekend degree programs, extended learning and Latin America …
  • Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析
    Summary Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathf …
  • Twitter, Inc.:企業のM&A・事業提携・投資動向
    Twitter, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Twitter, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Sprint Corporation:企業の戦略・SWOT・財務分析
    Sprint Corporation - Strategy, SWOT and Corporate Finance Report Summary Sprint Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆